Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideABTAbbott Laboratories
FinDog View：Neutral
LLYLilly (Eli)
FinDog View：Bullish
| Metric | ABT | LLY |
|---|
| Close | 102.36 | 1,137.82 |
| Market Cap | $177B | $1.07T |
| 1M | −7.26% | −3.83% |
| P/E (TTM) | 33.2 | 39.9 |
| Forward P/E | 18.1 | 28.5 |
| P/E 5-Yr Percentile | 66 | 6 |
| P/S | 3.9 | 13.4 |
| P/B | 3.5 | 31.5 |
| Dividend Yield | 1.98% | 0.75% |
| Latest Quarter Revenue | $11.2B | $23.0B |
| Revenue YoY | +7.8% | +47.7% |
| Gross Margin | 56.2% | 85.8% |
| Latest Quarter EPS | 0.61 | 7.94 |
| Avg Post-Earnings Move | ±1.6% | ±3.5% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.81% | 1.12% |
| 90-Day Net Insider Buying | −$46.7M | −$16.0M |
ABT · Revenue, Last 8 Quarters ($B)
LLY · Revenue, Last 8 Quarters ($B)
